{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:15:01Z","timestamp":1780100101080,"version":"3.54.0"},"reference-count":46,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2011,3,22]],"date-time":"2011-03-22T00:00:00Z","timestamp":1300752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2011,4]]},"abstract":"<jats:p><jats:bold>BACKGROUND AND PURPOSE<\/jats:bold>The human 5\u2010hydroxytryptamine<jats:sub>7<\/jats:sub>(h5\u2010HT<jats:sub>7<\/jats:sub>) receptor is G<jats:sub>s<\/jats:sub>\u2010coupled and stimulates the production of the intracellular signalling molecule cAMP. Previously, we reported a novel property of the h5\u2010HT<jats:sub>7<\/jats:sub>receptor: pseudo\u2010irreversible antagonists irreversibly inhibit forskolin\u2010stimulated (non\u2010receptor\u2010mediated) cAMP production. Herein, we sought to determine if competitive antagonists also affect forskolin\u2010stimulated activity and if this effect is common among other G<jats:sub>s<\/jats:sub>\u2010coupled receptors.<\/jats:p><jats:p><jats:bold>EXPERIMENTAL APPROACH<\/jats:bold>Recombinant cell lines expressing h5\u2010HT<jats:sub>7<\/jats:sub>receptors or other receptors of interest were briefly exposed to antagonists; cAMP production was then stimulated by forskolin and quantified by an immunocompetitive assay.<\/jats:p><jats:p><jats:bold>KEY RESULTS<\/jats:bold>In human embryonic kidney 293 cells stably expressing h5\u2010HT<jats:sub>7<\/jats:sub>receptors, all competitive antagonists inhibited nearly 100% of forskolin\u2010stimulated cAMP production. This effect was insensitive to pertussis toxin, that is, not G<jats:sub>i\/o<\/jats:sub>\u2010mediated. Potency to inhibit forskolin\u2010stimulated activity strongly correlated with h5\u2010HT<jats:sub>7<\/jats:sub>binding affinity (<jats:italic>r<\/jats:italic><jats:sup>2<\/jats:sup>= 0.91), indicating that the antagonists acted through h5\u2010HT<jats:sub>7<\/jats:sub>receptors to inhibit forskolin. Potency and maximal effects of clozapine, a prototypical competitive h5\u2010HT<jats:sub>7<\/jats:sub>antagonist, were unaffected by varying forskolin concentration. Antagonist interaction with h5\u2010HT<jats:sub>6<\/jats:sub>, human \u03b2<jats:sub>1<\/jats:sub>, \u03b2<jats:sub>2<\/jats:sub>, and \u03b2<jats:sub>3<\/jats:sub>adrenoceptors did not inhibit forskolin's activity.<\/jats:p><jats:p><jats:bold>CONCLUSIONS AND IMPLICATIONS<\/jats:bold>The inhibition of adenylate cyclase, as measured by forskolin's activity, is an underlying property of antagonist interaction with h5\u2010HT<jats:sub>7<\/jats:sub>receptors; however, this is not a common property of other G<jats:sub>s<\/jats:sub>\u2010coupled receptors. This phenomenon may be involved in the roles played by h5\u2010HT<jats:sub>7<\/jats:sub>receptors in human physiology. Development of h5\u2010HT<jats:sub>7<\/jats:sub>antagonists that do not elicit this effect would aid in the elucidation of its mechanisms and shed light on its possible physiological relevance.<\/jats:p>","DOI":"10.1111\/j.1476-5381.2010.01194.x","type":"journal-article","created":{"date-parts":[[2010,12,30]],"date-time":"2010-12-30T13:06:28Z","timestamp":1293714388000},"page":"1843-1854","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Antagonist interaction with the human 5\u2010HT<sub>7<\/sub>receptor mediates the rapid and potent inhibition of non\u2010G\u2010protein\u2010stimulated adenylate cyclase activity: a novel GPCR effect"],"prefix":"10.1111","volume":"162","author":[{"given":"MT","family":"Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Teitler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,3,22]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-009-1521-8"},{"key":"e_1_2_8_3_1","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0022-3565(24)37821-8","article-title":"Functional characterization of the recombinant human 5\u2010hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation","volume":"287","author":"Adham N","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"e_1_2_8_4_1","first-page":"S1","article-title":"Guide to Receptors and Channels (GRAC), 4th edition (2009)","volume":"158","author":"Alexander SPH","year":"2009","journal-title":"Br J Pharmacol"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.105.015396"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1959.tb00928.x"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.28.17469"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)49479-9"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.3109\/10606820308245"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.42.24631"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.19.7321"},{"key":"e_1_2_8_12_1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0026-895X(25)08958-8","article-title":"Drug efficacy at guanine nucleotide\u2010binding regulatory protein\u2010linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand","volume":"41","author":"Costa T","year":"1992","journal-title":"Mol Pharmacol"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.19.10098"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01115-1"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2004.07.002"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1997.68041372.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1993.1415"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(97)00036-1"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(01)00746-8"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)34558-7"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)34843-9"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.44.28700"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.108.052084"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704588"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002100000369"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568026023393796"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1790-05.2005"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm991151j"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(93)90149-L"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.12.5517"},{"key":"e_1_2_8_31_1","doi-asserted-by":"crossref","first-page":"13215","DOI":"10.1016\/S0021-9258(19)38287-0","article-title":"Characterization of the human gene for Gx alpha, a pertussis toxin\u2010insensitive regulatory GTP\u2010binding protein","volume":"265","author":"Matsuoka M","year":"1990","journal-title":"J Biol Chem"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.31.18655"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-004-2057-6"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(01)00169-3"},{"key":"e_1_2_8_35_1","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0022-3565(25)38596-4","article-title":"Binding of typical and atypical antipsychotic agents to 5\u2010hydroxytryptamine\u20106 and 5\u2010hydroxytryptamine\u20107 receptors","volume":"268","author":"Roth BL","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.6.3363"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)46830-X"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0804246105"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.106.024612"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(82)90155-1"},{"key":"e_1_2_8_41_1","first-page":"175","article-title":"Multiple serotonin receptor subtypes: molecular cloning and functional expression","volume":"8","author":"Teitler M","year":"1994","journal-title":"Crit Rev Neurobiol"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-010-2001-x"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701134"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701946"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.109.056283"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2000.0741685.x"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1347957"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2010.01194.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2010.01194.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T07:16:39Z","timestamp":1740813399000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2010.01194.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,22]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["10.1111\/j.1476-5381.2010.01194.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01194.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,22]]},"assertion":[{"value":"2011-03-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}